The effect of age and telomere length on immune function in the horse

Developmental and Comparative Immunology

Volumn 32, Issue 12, 2008, Pages 1409-1415

  Katepalli, Madhu P ^a   Adams, Amanda A ^a   Lear, Teri L ^a   Horohov, David W ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Aged; Equine; Immunosenescence; Inflammaging; Telomere

Indexed keywords

IMMUNOGLOBULIN G; MITOGENIC AGENT; TRITIUM;

ADOLESCENT; ANIMAL CELL; ARTICLE; CHROMOSOME SIZE; CONTROLLED STUDY; DNA SYNTHESIS; HORSE; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; INFLAMMATION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TELOMERE;

EQUIDAE; EUKARYOTA;

EID: 49649123254     PISSN: 0145305X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dci.2008.06.007     Document Type: Article

References (62)

1. Goronzy J.J., Fujii H., and Weyand C.M. Telomeres, immune aging and autoimmunity. Exp Gerontol 41 3 (2006) 246-251
2. Harley C.B. Human ageing and telomeres. Ciba Found Symp 211 (1997) 129-139
3. Taylor L.M., James A., Schuller C.E., Brce J., Lock R.B., and Mackenzie K.L. Inactivation of p16INK4a, with retention of pRB and p53/p21cip1 function, in human MRC5 fibroblasts that overcome a telomere-independent crisis during immortalization. J Biol Chem 279 42 (2004) 43634-43645
4. Haddad M.M., Xu W., Schwahn D.J., Liao F., and Medrano E.E. Activation of a cAMP pathway and induction of melanogenesis correlate with association of p16(INK4) and p27(KIP1) to CDKs, loss of E2F-binding activity, and premature senescence of human melanocytes. Exp Cell Res 253 2 (1999) 561-572
5. Jemielity S., Kimura M., Parker K.M., Parker J.D., Cao X., Aviv A., et al. Short telomeres in short-lived males: what are the molecular and evolutionary causes?. Aging Cell 6 2 (2007) 225-233
6. Blasco M.A. Telomeres and human disease: ageing, cancer and beyond. Nat Rev Genet 6 8 (2005) 611-622
7. Parwaresch R., and Krupp G. Telomere biology and the molecular basis of aging. Arkh Patol 64 3 (2002) 37-39
8. Vleck C.M., Haussmann M.F., and Vleck D. The natural history of telomeres: tools for aging animals and exploring the aging process. Exp Gerontol 38 7 (2003) 791-795
9. Jeyapalan J.C., Ferreira M., Sedivy J.M., and Herbig U. Accumulation of senescent cells in mitotic tissue of aging primates. Mech Ageing Dev 128 1 (2007) 36-44
10. Swanberg S.E., and Delany M.E. Differential expression of genes associated with telomere length homeostasis and oncogenesis in an avian model. Mech Ageing Dev 126 10 (2005) 1060-1070
11. Argyle D., Ellsmore V., Gault E.A., Munro A.F., and Nasir L. Equine telomeres and telomerase in cellular immortalisation and ageing. Mech Ageing Dev 124 6 (2003) 759-764
12. Brouilette S., Singh R.K., Thompson J.R., Goodall A.H., and Samani N.J. White cell telomere length and risk of premature myocardial infarction. Arterioscler Thromb Vasc Biol 23 5 (2003) 842-846
13. von Zglinicki T. Role of oxidative stress in telomere length regulation and replicative senescence. Ann NY Acad Sci 908 (2000) 99-110
14. Benetos A., Okuda K., Lajemi M., Kimura M., Thomas F., Skurnick J., et al. Telomere length as an indicator of biological aging: the gender effect and relation with pulse pressure and pulse wave velocity. Hypertension 37 2 (2001) 381-385
15. Samani N.J., Boultby R., Butler R., Thompson J.R., and Goodall A.H. Telomere shortening in atherosclerosis. Lancet 358 9280 (2001) 472-473
16. Cawthon R.M., Smith K.R., O'Brien E., Sivatchenko A., and Kerber R.A. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 361 9355 (2003) 393-395
17. Effros R.B. Ageing and the immune system. Novartis Found Symp 235 (2001) 130-139 [discussion 9-45, 46-9]
18. Krammer P.H., Arnold R., and Lavrik I.N. Life and death in peripheral T cells. Nat Rev Immunol 7 7 (2007) 532-542
19. Effros R.B., and Pawelec G. Replicative senescence of T cells: does the Hayflick Limit lead to immune exhaustion?. Immunol Today 18 9 (1997) 450-454
20. Solana R., and Pawelec G. Molecular and cellular basis of immunosenescence. Mech Ageing Dev 102 2-3 (1998) 115-129
21. Effros R.B., Dagarag M., Spaulding C., and Man J. The role of CD8+ T-cell replicative senescence in human aging. Immunol Rev 205 (2005) 147-157
22. Mariani E., Meneghetti A., Formentini I., Neri S., Cattini L., Ravaglia G., et al. Different rates of telomere shortening and telomerase activity reduction in CD8T and CD16 NK lymphocytes with ageing. Exp Gerontol 38 6 (2003) 653-659
23. Roth A., Baerlocher G.M., Schertzer M., Chavez E., Duhrsen U., and Lansdorp P.M. Telomere loss, senescence, and genetic instability in CD4+ T lymphocytes overexpressing hTERT. Blood 106 1 (2005) 43-50
24. Rufer N., Brummendorf T.H., Kolvraa S., Bischoff C., Christensen K., Wadsworth L., et al. Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood. J Exp Med 190 2 (1999) 157-167
25. Son N.H., Joyce B., Hieatt A., Chrest F.J., Yanovski J., and Weng N.P. Stable telomere length and telomerase expression from naive to memory B-lymphocyte differentiation. Mech Ageing Dev 124 4 (2003) 427-432
26. Son N.H., Murray S., Yanovski J., Hodes R.J., and Weng N. Lineage-specific telomere shortening and unaltered capacity for telomerase expression in human T and B lymphocytes with age. J Immunol 165 3 (2000) 1191-1196
27. Effros R.B. Telomerase induction in T cells: a cure for aging and disease?. Exp Gerontol 42 5 (2007) 416-420
28. Akbar A.N., and Vukmanovic-Stejic M. Telomerase in T lymphocytes: use it and lose it?. J Immunol 178 11 (2007) 6689-6694
29. Honda M., Mengesha E., Albano S., Nichols W.S., Wallace D.J., Metzger A., et al. Telomere shortening and decreased replicative potential, contrasted by continued proliferation of telomerase-positive CD8+CD28(lo) T cells in patients with systemic lupus erythematosus. Clin Immunol 99 2 (2001) 211-221
30. Baerlocher G.M., Vulto I., de Jong G., and Lansdorp P.M. Flow cytometry and FISH to measure the average length of telomeres (flow FISH). Nat Protoc 1 5 (2006) 2365-2376
31. Breathnach C.C., Sturgill-Wright T., Stiltner J.L., Adams A.A., Lunn D.P., and Horohov D.W. Foals are interferon gamma-deficient at birth. Vet Immunol Immunopathol 112 3-4 (2006) 199-209
32. Allsopp R.C., and Harley C.B. Evidence for a critical telomere length in senescent human fibroblasts. Exp Cell Res 219 1 (1995) 130-136
33. Slagboom P.E., and Vijg J. The dynamics of genome organization and expression during the aging process. Ann NY Acad Sci 673 (1992) 58-69
34. Vaziri H., Dragowska W., Allsopp R.C., Thomas T.E., Harley C.B., and Lansdorp P.M. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA 91 21 (1994) 9857-9860
35. Haussmann M.F., Winkler D.W., O'Reilly K.M., Huntington C.E., Nisbet I.C., and Vleck C.M. Telomeres shorten more slowly in long-lived birds and mammals than in short-lived ones. Proc Biol Sci 270 1522 (2003) 1387-1392
36. Nakagawa S., Gemmell N.J., and Burke T. Measuring vertebrate telomeres: applications and limitations. Mol Ecol 13 9 (2004) 2523-2533
37. Pawelec G., Akbar A., Caruso C., Solana R., Grubeck-Loebenstein B., and Wikby A. Human immunosenescence: is it infectious?. Immunol Rev 205 (2005) 257-268
38. Franceschi C., Bonafe M., and Valensin S. Human immunosenescence: the prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space. Vaccine 18 16 (2000) 1717-1720
39. Pawelec G., Wagner W., Adibzadeh M., and Engel A. T cell immunosenescence in vitro and in vivo. Exp Gerontol 34 3 (1999) 419-429
40. Pawelec G. Molecular and cell biological studies of ageing and their application to considerations of T lymphocyte immunosenescence. Mech Ageing Dev 79 1 (1995) 1-32
41. Horohov D.W., Dimock A., Guirnalda P., Folsom R.W., McKeever K.H., and Malinowski K. Effect of exercise on the immune response of young and old horses. Am J Vet Res 60 5 (1999) 643-647
42. Guirnalda P.D., Malinowski K., Roegner V., and Horohov D.W. Effects of age and recombinant equine somatotropin (eST) administration on immune function in female horses. J Anim Sci 79 10 (2001) 2651-2658
43. Horohov D.W., Kydd J.H., and Hannant D. The effect of aging on T cell responses in the horse. Dev Comp Immunol 26 1 (2002) 121-128
44. Von Zglinicki T. Replicative senescence and the art of counting. Exp Gerontol 38 11-12 (2003) 1259-1264
45. Weng N. Interplay between telomere length and telomerase in human leukocyte differentiation and aging. J Leukoc Biol 70 6 (2001) 861-867
46. Ginaldi L., De Martinis M., D'Ostilio A., Marini L., Loreto M.F., Corsi M.P., et al. Cell proliferation and apoptosis in the immune system in the elderly. Immunol Res 21 1 (2000) 31-38
47. Steger M.M., Maczek C., and Grubeck-Loebenstein B. Peripheral blood dendritic cells reinduce proliferation in in vitro aged T cell populations. Mech Ageing Dev 93 1-3 (1997) 125-130
48. Straub R.H., Miller L.E., Scholmerich J., and Zietz B. Cytokines and hormones as possible links between endocrinosenescence and immunosenescence. J Neuroimmunol 109 1 (2000) 10-15
49. Miller R.A., Garcia G., Kirk C.J., and Witkowski J.M. Early activation defects in T lymphocytes from aged mice. Immunol Rev 160 (1997) 79-90
50. Effros R.B. Role of T lymphocyte replicative senescence in vaccine efficacy. Vaccine 25 4 (2007) 599-604
51. Bellei N.C., Carraro E., Castelo A., and Granato C.F. Risk factors for poor immune response to influenza vaccination in elderly people. Braz J Infect Dis 10 4 (2006) 269-273
52. McElhaney J.E. The unmet need in the elderly: designing new influenza vaccines for older adults. Vaccine 23 Suppl. 1 (2005) S10-S25
53. Burns E.A., Lum L.G., L'Hommedieu G., and Goodwin J.S. Specific humoral immunity in the elderly: in vivo and in vitro response to vaccination. J Gerontol 48 6 (1993) B231-B236
54. McFarlane D., Sellon D.C., and Gibbs S.A. Age-related quantitative alterations in lymphocyte subsets and immunoglobulin isotypes in healthy horses. Am J Vet Res 62 9 (2001) 1413-1417
55. Sheoran A.S., Timoney J.F., Holmes M.A., Karzenski S.S., and Crisman M.V. Immunoglobulin isotypes in sera and nasal mucosal secretions and their neonatal transfer and distribution in horses. Am J Vet Res 61 9 (2000) 1099-1105
56. Martens U.M., Brass V., Sedlacek L., Pantic M., Exner C., Guo Y., et al. Telomere maintenance in human B lymphocytes. Br J Haematol 119 3 (2002) 810-818
57. Franceschi C., Bonafe M., Valensin S., Olivieri F., De Luca M., Ottaviani E., et al. Inflamm-aging: an evolutionary perspective on immunosenescence. Ann NY Acad Sci 908 (2000) 244-254
58. Giunta S. Is inflammaging an auto[innate]immunity subclinical syndrome?. Immun Ageing 3 (2006) 12
59. Romanyukha A.A., and Yashin A.I. Age related changes in population of peripheral T cells: towards a model of immunosenescence. Mech Ageing Dev 124 4 (2003) 433-443
60. Weng N.P., Palmer L.D., Levine B.L., Lane H.C., June C.H., and Hodes R.J. Tales of tails: regulation of telomere length and telomerase activity during lymphocyte development, differentiation, activation, and aging. Immunol Rev 160 (1997) 43-54
61. Wojda A., and Witt M. Manifestations of ageing at the cytogenetic level. J Appl Genet 44 3 (2003) 383-399
62. Slagboom P.E., Droog S., and Boomsma D.I. Genetic determination of telomere size in humans: a twin study of three age groups. Am J Hum Genet 55 5 (1994) 876-882